Related Experiment Videos
Active specific adjuvant immunotherapy with vaccinia melanoma oncolysate
S D Scoggin1, M Sivanandham, R G Sperry
1Department of Surgery, Mount Sinai Medical Center, Miami Beach, FL.
Annals of Plastic Surgery
|January 1, 1992
Abstract:
Vaccinia melanoma oncolysate is an investigative agent for active specific adjuvant immunotherapy. Viral oncolysate work in animals has led to application of this treatment in humans. Success of initial trials in treatment of melanoma has led to a phase III randomized, prospective, double-blind, multi-institutional trial, which is currently under way.